# Sunshine Biopharma (SBFM) — News

SBFM · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/sbfm/news

## Recent headlines

- [Trading release/resumed: (SBFM) Reason not available](https://www.ainvest.com/news/trading-release-resumed-sbfm-reason-2610) — AInvest Wire, Oct 7, 2026
  Trading in shares of Sunshine Biopharma, Inc. (NASDAQ: SBFM) has resumed following a prior trading halt, though the specific reason for the suspension remains undisclosed. The resumption of trading comes amid ongoing developments in the company’s pipeline, which includes the advancement of…
- [Trading released/resumed: (SBFM) Reason not available](https://www.ainvest.com/news/trading-released-resumed-sbfm-reason-2610) — AInvest Wire, Oct 7, 2026
  Trading in shares of Sunshine Biopharma Inc. (NASDAQ: SBFM) was temporarily suspended and has now resumed, according to recent market updates. The specific reason for the trading halt has not been disclosed at this time. Investors are advised to monitor official announcements from the company or…
- [Trading halted (SBFM) due to limit-up limit-down trading pause](https://www.ainvest.com/news/trading-halted-sbfm-due-limit-limit-trading-pause-2610-94) — AInvest Wire, Oct 7, 2026
  Trading in SBFM was temporarily suspended on October 7, 2026, due to a [limit-up limit-down trading pause][1]. This mechanism is designed to prevent excessive volatility and provide time for market participants to reassess positions during periods of sharp price movements. The pause was triggered…
- [Trading halted: (SBFM) Due to limit-up limit-down trading pause](https://www.ainvest.com/news/trading-halted-sbfm-due-limit-limit-trading-pause-2610) — AInvest Wire, Oct 7, 2026
  Trading in the shares of SBFM has been temporarily suspended due to a limit-up limit-down trading pause, according to regulatory filings. This type of halt is typically implemented when a stock's price moves rapidly in a short period, triggering circuit breakers designed to stabilize trading and…
- [Sunshine Biopharma - Board authorized to effect reverse split of common stock up to 1-for-20 - SEC filing](https://www.ainvest.com/news/sunshine-biopharma-board-authorized-effect-reverse-split-common-stock-1-20-sec-filing-2609) — AInvest Wire, Sep 16, 2026
  Sunshine Biopharma Inc. (NASDAQ: SBFM) has authorized its board of directors to effect a reverse stock split of its issued and outstanding common stock, with a potential ratio of up to 1-for-20, according to a recent SEC filing. The board retains discretion to determine whether the reverse split…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).